Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 006317
Company: LILLY
Company: LILLY
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| NEOTRIZINE | TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE) | 167MG;167MG;167MG | TABLET;ORAL | Discontinued | None | No | No |
| NEOTRIZINE | TRISULFAPYRIMIDINES (SULFADIAZINE;SULFAMERAZINE;SULFAMETHAZINE) | 167MG/5ML;167MG/5ML;167MG/5ML | SUSPENSION;ORAL | Discontinued | None | No | No |
| SULFONAMIDES DUPLEX | SULFADIAZINE; SULFAMERAZINE | 250MG/5ML;250MG/5ML | SUSPENSION;ORAL | Discontinued | None | No | No |
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English